We compared the expression of major
histocompatibility complex (MHC; HLA class 1 and 11)
antigens and the presence of tumor-infiltrating
mononuclear cells presenting S 100 protein (S 100),
CD68 antigen, or CD45RO antigen in formalin-fixed,
paraffin-embedded tissue sections of 10 renal cell
carcinomas and 9 renal cell adenomas using immunohistochemistry.
The expression of B2-microglobulin
(B2MG) as an HLA class 1 antigen in al1 10 cases
(100%) and that of HLA-DR/a as an HLA class 11
antigen in 7 of 10 cases (70%) of carcinoma was
stronger than that in the adjacent proximal convoluted
tubule, but was respectively not different to weaker in 8
of 9 cases and not different to markedly weaker in al1
cases of adenoma. Furthermore, there was comparatively
dense infiltration by S 100(+) antigen-presenting cells in
the carcinomas, but almost none in the adenomas and
generally dense infiltration by CD45RO(+) T cells and
CD68(+) macrophages in the carcinomas, but little to
none in the adenomas. We concluded that the generaily
enhanced expression of MHC antigens in carcinomas
must be an immunophenotypic deviation from not only
the adjacent proximal convoluted tubule but also
adenomas, and that the predominant infiltration of
antigen-presenting cells, T cells and macrophages in the
carcinomas, but not in the adenomas, reflects the anticancer
immune reactio